bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
http://www.ncbi.nlm.nih.gov/pubmed/38234051
 
Behrokh Farahmand; Hamideh Ofoghi; Sohrab Sam
 
Jan 18, 2024
 
Prev Next